PEG-peptoid - Xfibra

Drug Profile

PEG-peptoid - Xfibra

Alternative Names: PEG-30kDa-peptoid; Polyethylene glycol-peptoid

Latest Information Update: 19 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Xfibra
  • Class Peptoids; Polyethylene glycols
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Liver cirrhosis

Most Recent Events

  • 19 Jul 2016 Preclinical trials in Cirrhosis in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top